Abstract
We report the French experience regarding pregnancies in maternal phenylketonuria (PKU). In 2001, a questionnaire was sent to each referring PKU specialist in the 20 centres of each region of France, collecting reports on 135 pregnancies in 79 women born between 1958 and 1980. The majority of the 135 pregnancies occurred after 1990. A total of 42 women were informed of the risks of untreated pregnancy, while 26 were not informed (no data for 11). A strict diet was achieved in 83% of informed and in 16% of uninformed mothers prior to conception. Healthy offspring were observed in 43% of the 135 pregnancies, spontaneous abortions in 10.4%, elective abortions in 4.4%, therapeutic abortions in 12.6%, and embryopathies (EP) in 21.5%. In 8.1% of cases, the outcomes (in earliest pregnancies) are unknown. The proportion of healthy children increased over time and reached 80% of the pregnancies of informed females. There were seven heart defects, all in cases of EP, but although microcephaly and intrauterine growth retardation (IUGR) were almost constant in EP, we also found nine healthy children with IUGR. A continuum between EP and healthy children is suggested. The anthropometric data of the mothers showed that their body mass index (BMI) distribution was shifted to the left compared to women of the general population. This lower BMI and poor weight gain during pregnancy could contribute to the IUGR observed in normal babies whose mothers received a phenylalanine-restricted diet during pregnancy. Conclusion:the information and the preconception diet are effective for avoiding embryopathies in maternal phenylketonuria. Nutritional parameters can influence fetal growth and the nutritional state must be closely monitored throughout pregnancies of women with phenylketonuria.
Similar content being viewed by others
Abbreviations
- BMI :
-
body mass index
- EA :
-
elective abortion
- EP :
-
embryopathy
- IUGR :
-
intrauterine growth retardation
- MPKU :
-
maternal phenylketonuria
- MPKUCS :
-
maternal phenylketonuria collaborative study
- Phe :
-
phenylalanine
- PKU :
-
phenylketonuria
- SA :
-
spontaneous abortion
- TA :
-
therapeutic abortion
References
Abadie V, Berthelot J, Feillet F, Maurin N, Mercier A, Ogier de Baulny H, de Parscau L (2001) Neonatal screening and long-term follow-up of phenylketonuria: the French database. Early Hum Dev 65: 149–158
Acosta PB, Blascovics M, Cloud H, Lis E, Stroud E, Wenz E (1982) Nutrition in pregnancy in women with hyperphenylalaninemia. J Am Diet Assoc 80: 443–450
Cohen J, Madelenat P, Levy-Toledano R (2000) La demande de soins–grossesse. Gynécologie et santé des femmes, quel avenir en France. ESKA Eds, pp 84–102
Dent CE (1957) Discussion of Armstrong MD, the relation of biochemical abnormality to the development of mental defect in phenylketonuria. Etiologic factors in mental retardation. 23rd Ross Pediatric Research Conference. Ross Laboratories, Columbus, pp 32–33
Güttler F, Lou H, Andresen J, Kok K, Mikkelsen I, Nielsen KB, Nielsen JB (1990) Cognitive development in offspring of untreated and preconceptionally treated maternal phenylketonuria. J Inherit Metab Dis 13: 665–671
Hanley WB, Platt LD, Bachman RP, Buist N, Geraghty MT, Isaacs J, O’Flynn ME, Rhead WJ, Seidlitz G, Tishler B (1999) Undiagnosed maternal phenylketonuria: the need for prenatal selective screening or case finding. Am J Obstet Gynecol 180: 986–994
Koch R, Friedman E, Azen C, Hanley W, Levy H, Matalon R, Rouse B, Trefz F, Waisbren S, Michals-Matalon K, Acosta P, Güttler F, Ullrich K, Platt L, de la Cruz F (2000) The international collaborative study of maternal phenylketonuria. Eur J Pediatr 159: S156–S160
Koch R, Hanley W, Levy H, Matalon K, Matalon R, Rouse B, Trefz F, Güttler F, Azen C, Platt L, Waisbren S, Widaman K, Ning J, Friedman EG, de la Cruz F (2003) The maternal phenylketonuria international study: 1984–2002. Pediatrics 112: 1523–1529
Lee PJ (2000) Comments on the international collaborative study of maternal phenylketonuria status report 1998. Eur J Pediatr 159: S161–S162
Levy HL, Waisbren SE, Lobbregt D, Alfred E, Leviton A, KochR, Hanley WB, Rouse B, Matalon R, de la Cruz F (1996) Maternal non-phenylketonuric mild hyperphenylalaninemia. Eur J Pediatr 155: S20–S25
Matalon R (2000) Maternal PKU: Pregnancy and child outcomes in relation to dietary control. In consensus development conference on phenylketonuria (PKU): screening and management. NIH Bethesda, October 16–18, pp 97–101
Michals K, Acosta PB, Austin V, Castiglioni L, Rohr F, Wenz E, Azen C (1996) Nutrition and reproductive outcome in maternal phenylketonuria. Eur J Pediatr 155[Suppl 1]: S165–S168
Platt LD, Koch R, Hanley WB, Levy HL, Matalon R, Rouse B et al (2000) The international study of pregnancy outcome in women with maternal phenylketonuria: report of a 12-year study. Am J Obstet Gynecol 182: 326–333
Rouse B, Azen C (2004) Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy. J Pediatr 144: 235–239
Rouse B, Azen C, Koch R, Matalon R, Hanley W, de la Cruz F, Trefz F, Friedman E, Shifrin H (1997) Maternal phenylketonuria collaborative study (MPKUCS) offspring: facial anomalies, malformations and early neurological sequelae. Am J Med Genet 69: 89–95
Saliba Z, Bah G, Martin D, Abadie V, Azar Z, Fraisse A, Sidi D, Kachaner J, Bonnet D (2000) Pseudo-inherited form of left heart obstructive defects revealing maternal phenylketonuria. Arch Mal Coeur Vaiss 93: 649–652
Salize HJ, Funders-Bucker B, Knorrek U, Kolbe S, Pietsch V, Seidlitz G, Ullrich K, Trefz FK (1992) Maternal phenylketonuria. Problems in detecting and risk educating identified females. Monatsschr Kinderheilkd 140: 42–46
Thibaud D, Ploussard JP, Vaquant PO, Chemouny S, Kleitz T (1998) Diagnosis of phenylketonuria in a 35-year-old mother in relation to prenatal diagnosis of intrauterine growth retardation with microcephaly. Arch Pédiatr 5: 1229–1231
Vidailhet M, Feillet F (2002) Dépistage neonatal. Le défi médical:du malade à sa descendance. Arch Pediatr 9[Suppl 2]: 154s–156 s
Vidailhet M, Feillet F, Abadie V (2002) Grossesse chez la femme atteinte de phénylcétonurie. Mise à jour en gynécologie et obstétrique, pp 93-99
Acknowledgements
We thank all the French referring PKU specialists who participated in this study and the Association Française pour le Dépistage et la Prévention des Handicaps de l’Enfant for its support of this study. We also thank Alan Strickland for his help in the preparation of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Additional information
On behalf of the PKU workgroup of the Association Française pour le Dépistage et la Prévention des Handicaps de l’Enfant (AFDPHE)
Rights and permissions
About this article
Cite this article
Feillet, F., Abadie, V., Berthelot, J. et al. Maternal phenylketonuria: the French survey. Eur J Pediatr 163, 540–546 (2004). https://doi.org/10.1007/s00431-004-1482-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-004-1482-1